MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaad.2024.03.039

Медицинская библиотека · Journal of the American Academy of Dermatology · 2024

Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study.

Hasan Iraj, Parsons Lauren, Duran Sabrina, Zinn Zachary

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Dupilumab, a human monoclonal antibody targeting the interleukin 4 alpha receptor, is used for treatment of moderate to severe atopic dermatitis (AD). Previous studies have reported diagnoses of cutaneous T cell lymphoma (CTCL) after dupilumab use.

OBJECTIVE

Investigate the risk of CTCL after dupilumab use in patients with AD.

METHODS

Using the TrinetX database, incidence of cutaneous and lymphoid malignancies including CTCL was compared between a cohort of patients with AD who used dupilumab and a cohort of patients with AD who never used dupilumab. A second analysis excluding prior disease-modifying antirheumatic drug use was performed. Propensity score matching was performed to control for covariates.

RESULTS

An increased risk of CTCL was found in the cohort of AD patients who used dupilumab (odds ratio 4.1003, 95% confidence interval 2.055-8.192). The increased risk persisted after exclusion of prior disease-modifying antirheumatic drug use. Risk was not increased for other cutaneous or lymphoid malignancies. Most (27/41) cases of CTCL were diagnosed more than 1 year after dupilumab use.

LIMITATIONS: There is potential for misclassification in the database. Severity of AD could not be assessed. Association between dupilumab and CTCL does not prove causality.

CONCLUSION

Dupilumab use is associated with an increased risk of CTCL in patients with AD in this cohort.

Для цитирования: Hasan Iraj, Parsons Lauren, Duran Sabrina, Zinn Zachary. Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study.. Journal of the American Academy of Dermatology. 2024. DOI: 10.1016/j.jaad.2024.03.039.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.